Due to the ongoing lead contamination in Flint, Michigan, the Centers for Disease Control and Prevention has provided an outline about lead in water. The outline covers the effects of high lead exposure to the removal of lead contamination in water. For more information, please visit: http://www.cdc.gov/nceh/lead/tips/water.htm
Adapted from NLM:
The NIH Director, Dr. Francis Collins, MD, formed a working group of the Advisory Committee to the NIH Director (ACD) for the purpose of reviewing the programs of NLM and recommendations for the future. The working group submitted a Request for Information from February 13 to March 13, 2015. There were 650 respondents in total. After the RFI was completed and reviewed, NLM found a wealth of information about its products, services and suggestions. For more information, please visit: http://infocus.nlm.nih.gov/2016/02/01/nih-request-for-information-yields-important-public-input-on-value-of-nlm-products-and-services/
Adapted from: FDA blog, January 27, 2016
The importance of diversity in clinical trials cannot be underscored. Controlled clinical trials form the basis of evidence for evaluating whether a medical product is effective prior to the product being approved and marketed. One challenge for the Food and Drug Administration (FDA) is ensuring that research participants are representative of the patients who will use the medical product. A variety of people should have the opportunity to participate in trials, be knowledgeable about upcoming trials, have access to new therapies and have the chance to contribute to the betterment of medical treatment for everyone. Historically, the elderly, women and racial/ethnic minorities have been underrepresented in trials. Literature has well-documented this under-representation in recent years, particularly for women in some cardiovascular trials and general inclusion of black/African-American and minority participants in clinical trials. In response to these concerns, Congress included FDASIA Section 907: Inclusion of Demographic Subgroups in Clinical Trials in the Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012 , http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/FDASIA/ucm389100.htm giving FDA direction to evaluate this issue and take action. FDA has responded in multiple ways, including the creation of Drug Trials Snapshots more than a year ago that provides the public with a demographic profile of people participating in clinical trials for approved drugs. FDA notes that an evaluation of the Snapshots program shows that some groups, especially ethnic and racial groups, aren’t always well represented in clinical trials.
Increasing diversity in clinical trials is a priority for FDA. To that end, in 2016, the agency is planning a variety of activities and collaborations to push for greater inclusion, including more minority participation. For example:
- FDA’s Office of Minority Health has developed a variety of tools to support clinical trial participation, including collaboration with the National Library of Medicine to help consumers and patients find clinical trials, educational materials on trials, as well as a multi-media campaign highlighting the importance of clinical trial participation. These materials are designed to urge those underrepresented in clinical trials to find out more information, and consider enrolling.
- FDA’s Office of Women’s Health launched its Diverse Women in Clinical Trials initiative. Developed in collaboration with the National Institute of Health’s Office of Research on Women’s Health, this multipronged effort will raise awareness and share best practices about clinical research design, recruitment, and subpopulation analyses.
- FDA’s biostatisticians, trial design experts, and quantitative scientists will continue to work with the research community to develop methods to refine our approach to the conduct and analysis of trials to provide the best estimates of treatment effects for diverse populations.
- FDA will continue our commitment to include patient advocacy groups to engage patients in clinical trial design, feedback and evaluation from a patient’s perspective. By engaging patients early in the trial design process, feasibility and participation may be improved.
- The FDA’s Office of External Affairs plans to publish a consumer update describing what it is like to participate in a clinical trial and encouraging the public to enroll in trials.
- The FDA has declared 2016 the year of more diversity in clinical trials. For more information see: http://blogs.fda.gov/fdavoice/index.php/2016/01/
Adapted from: NIH News in Health, February 2016 issue
Check out the February issue of NIH News in Health, the monthly newsletter bringing you practical health news and tips based on the latest NIH research. To search for more trusted health information from NIH, bookmark http://health.nih.gov.
|Technologies Enhance Tumor Surgery Helping Surgeons Spot and Remove Cancer NIH-funded researchers are developing new technologies to help surgeons figure out exactly where cancerous tumors end and healthy tissue begins. Read more about technologies for cancer surgery.|
|Focusing on Fibromyalgia A Puzzling and Painful Condition Fibromyalgia is a long-term condition marked by pain and fatigue. It can be hard to diagnose, but treatment can help. Read more about fibromyalgia.|
Please NIH’s website http://www.nih.gov/ for current authoritative health information.
MedlinePlus posted a warning from the World Health Organization last week entitled “Zika Virus Expected to Spread North Through U.S.: WHO“.
As this is an emerging threat with new updates daily, here are a couple of websites to consult for the latest news:
- Pan American Health Organization’s Zika Virus page
- The Centers for Disease Control’s Zika Virus page
- National Library of Medicine’s Disaster Information Management Resource Center’s Zika Virus page
As of January 27 there are also two new Medical Subject Headings available for searching MEDLINE/PubMed: Zika Virus Infection and Zika Virus.
View this posting on the LSU Health Shreveport HR website
Digital and Information Services Librarian, Medical Library
Posted Date: 1/28/2016
Position Number: 28235
Salary Range: Negotiable
Location: LSU Health Shreveport
Posting open until filled
Required: Master’s degree in Library or Information Science from an American Library Association (ALA)-accredited institution. Experience in searching health sciences information databases. Must have excellent communication and interpersonal skills, ability to work in a team-oriented, collaborative environment, problem solving ability, excellent computer skills, and ability to work effectively with colleagues, students, faculty, and staff.
Desired: Experience in a library, preferably in a health sciences environment. Familiarity or experience with systematic reviews. Academy of Health Information Professionals credentialing. Ability to assist with a writing consultation service. Familiarity with genetic and/or molecular databases. Willingness to learn new technologies.
The Department of Medical Library Science is seeking an enthusiastic, innovative librarian and expert searcher to assist faculty, researchers, and students with their information needs through literature searching, participation in morning report, and teaching information appraisal skills. This is a full-time faculty position, tenure-track if appointed at assistant librarian/assistant professor level or higher. The person in this position designs courses and/or tutorials, teaches audiences of varying education levels, provides outreach, serves as a liaison to other departments, and provides assistance with writing. Broad professional responsibilities include writing grant proposals, participation in professional associations which support library and information science or health care, participation in pertinent continuing education opportunities, conducting research and publishing.
The Library staff is a congenial and diverse group, always seeking new and improved ways to provide services and resources.
Applicants should submit CV and three letters of reference to the Faculty Staffing Office at LSU Health Shreveport via email to: ShvFacultyRecruitment@lsuhsc.edu or by mail to the address below.
LSU Health Shreveport
Department of Human Resource Management
Attn: Faculty Recruitment
1501 Kings Highway, P.O. Box 33932
Shreveport, LA 71130-3932
We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any other characteristic protected by law.
Adapted from Association of Schools & Programs of Public Health:
The misuse of antibiotics can have harmful effects. Over time, bacteria can become resistant to antibiotic medication. This becomes worse when individuals live in close quarters. One primary example is nursing homes. Dr. Darcy McMaughan, assistant professor at the Texas A&M Health Science Center School of Public Health, is helping health professionals decide when and when not to prescribe antibiotics, in continuation of work begun by Regents Professors Dr. Charles D. Phillips, and Dr. Catherine Hawes. As part of a three-year, $211,368 contract with the American Institutes for Research through the U.S. Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ), McMaughan is developing a Nursing Home Antibiotic Stewardship Guide. For more information, please visit: http://www.aspph.org/texas-am-working-to-protect-a-precious-resource-antibiotics-in-nursing-homes/
The Centers for Disease Control and Prevention (CDC) Reports High Sodium Intake is Still Problematic in the United States
Adapted from CDC:
A report published by the Centers for Disease Control and Prevention (CDC) has announced that most Americans consume too much sodium for a healthy diet. In the report, more than 90 percent of children and 89 percent of adults aged 19 and older eat too much sodium. CDC researchers analyzed dietary data from the 2009-2012 National Health Nutrition and Examination Surveys (NHANES) to calculate how much sodium Americans are eating. Nearly 15,000 individuals were included in the study. For more information, please visit: http://www.cdc.gov/media/releases/2016/p0106-sodium-intake.html
Adapted from The Association of Schools & Programs of Public Health Website News dated January 7, 2016
The National Institutes of Health will fund a set of genome sequencing and analysis centers whose research will focus on understanding the genomic bases of common and rare human diseases. The National Human Genome Research Institute (NHGRI), part of NIH, January 14, 2016 launched the Centers for Common Disease Genomics (CCDG), which will use genome sequencing to explore the genomic contributions to common diseases such as heart disease, diabetes, stroke and autism. NHGRI also announced the next phase of a complementary program, the Centers for Mendelian Genomics (CMG), which will continue investigating the genomic underpinnings of rare, typically inherited diseases, such as cystic fibrosis and muscular dystrophy. “Advances in DNA sequencing are creating tremendous new opportunities for exploring how the genome plays a role in human disease,” said NHGRI Director Eric Green, M.D., Ph.D. “Our continued focus on both rare and common diseases promises to reveal important aspects about the genomic architecture of a wide range of human disorders.”CCDG researchers plan to examine a select group of disorders in order to develop approaches for using genome sequencing to study common disease more broadly. By sequencing an expected 150,000 to 200,000 genomes of individuals with these diseases, the CCDG program aims to improve understanding of how genomic differences among people influence disease risk and to develop models for future studies of common disease.
NHGRI is one of the 27 institutes and centers at the National Institutes of Health. The NHGRI Extramural Research Program supports grants for research and training and career development at sites nationwide. Additional information about NHGRI can be found at www.genome.gov.